259 related articles for article (PubMed ID: 9769294)
1. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis.
Takahashi T; Munakata M; Suzuki I; Kawakami Y
Am J Respir Crit Care Med; 1998 Oct; 158(4):1294-8. PubMed ID: 9769294
[TBL] [Abstract][Full Text] [Related]
2. Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis.
Nakajima M; Manabe T; Niki Y; Matsushima T
Thorax; 1998 Sep; 53(9):809-11. PubMed ID: 10319067
[TBL] [Abstract][Full Text] [Related]
3. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis.
Lin FC; Chen YC; Chang SC
Mayo Clin Proc; 2008 Dec; 83(12):1344-9. PubMed ID: 19046553
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids.
Honda Y; Kuroki Y; Matsuura E; Nagae H; Takahashi H; Akino T; Abe S
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1860-6. PubMed ID: 8520747
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of the modified lavage technique of Bingisser and KL-6 monitoring in a patient with pulmonary alveolar proteinosis.
Ishikawa N; Kondo K; Oguri T; Kamitsuna M; Sakurai J; Fujitaka K; Yamasaki M; Maeda H; Isobe T; Kohno N
Intern Med; 2002 May; 41(5):381-5. PubMed ID: 12058888
[TBL] [Abstract][Full Text] [Related]
6. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
[TBL] [Abstract][Full Text] [Related]
7. [Pathologic feature and diagnosis of pulmonary alveolar proteinosis].
Meng ZL; Liu HR; Liang ZY; Zhang SY
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):575-8. PubMed ID: 16468308
[TBL] [Abstract][Full Text] [Related]
8. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis.
Bandoh S; Fujita J; Ohtsuki Y; Ueda Y; Hojo S; Tokuda M; Dobashi H; Kurata N; Yoshinouchi T; Kohno N; Takahara J
Ann Rheum Dis; 2000 Apr; 59(4):257-62. PubMed ID: 10733471
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia.
Kohno N; Yokoyama A; Hirasawa Y; Kondo K; Fujino S; Abe M; Hiwada K
Respir Med; 1997 Oct; 91(9):558-61. PubMed ID: 9415357
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study of KL-6 in pulmonary tuberculosis].
Inoue T; Ishida A; Yamamoto T; Seki R; Maruyama H; Noda T; Yashiro T; Tadokoro M
Nihon Kokyuki Gakkai Zasshi; 2001 Aug; 39(8):553-8. PubMed ID: 11681019
[TBL] [Abstract][Full Text] [Related]
11. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease.
Kohno N; Awaya Y; Oyama T; Yamakido M; Akiyama M; Inoue Y; Yokoyama A; Hamada H; Fujioka S; Hiwada K
Am Rev Respir Dis; 1993 Sep; 148(3):637-42. PubMed ID: 8368634
[TBL] [Abstract][Full Text] [Related]
12. A case of myelodysplastic syndrome complicated by pulmonary alveolar proteinosis with a high serum KL-6 level.
Kajiume T; Yoshimi S; Nagita A; Kobayashi K; Kataoka N; Nakajima M; Matsushima T
Pediatr Hematol Oncol; 1999; 16(4):367-71. PubMed ID: 10407875
[TBL] [Abstract][Full Text] [Related]
13. Elevation of tumour markers in serum and bronchoalveolar lavage fluid in pulmonary alveolar proteinosis.
Hirakata Y; Kobayashi J; Sugama Y; Kitamura S
Eur Respir J; 1995 May; 8(5):689-96. PubMed ID: 7656937
[TBL] [Abstract][Full Text] [Related]
14. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of serum KL-6 levels in summer-type hypersensitivity pneumonitis].
Nakajima M; Toshiaki M; Yoshida K; Niki Y; Matsushima T
Nihon Kokyuki Gakkai Zasshi; 1998 Sep; 36(9):763-70. PubMed ID: 9866978
[TBL] [Abstract][Full Text] [Related]
16. Differences in the immunolocalization of surfactant protein (SP)-A, SP-D, and KL-6 in pulmonary alveolar proteinosis.
Kobayashi M; Takeuchi T; Ohtsuki Y
Pathol Int; 2008 Mar; 58(3):203-7. PubMed ID: 18251786
[TBL] [Abstract][Full Text] [Related]
17. Serum antibody against granulocyte/macrophage colony-stimulating factor and KL-6 in idiopathic pulmonary alveolar proteinosis.
Nara M; Sano K; Ogawa H; Tamada T; Nagaoka M; Okada K; Watanabe M; Moriya T; Miki H; Nakata K; Ichinose M; Hattori T
Tohoku J Exp Med; 2006 Apr; 208(4):349-54. PubMed ID: 16565598
[TBL] [Abstract][Full Text] [Related]
18. Elevated BALF concentrations of alpha- and beta-defensins in patients with pulmonary alveolar proteinosis.
Mukae H; Ishimoto H; Yanagi S; Ishii H; Nakayama S; Ashitani J; Nakazato M; Kohno S
Respir Med; 2007 Apr; 101(4):715-21. PubMed ID: 17000097
[TBL] [Abstract][Full Text] [Related]
19. Extracellular 20S proteasome in BAL and serum of patients with alveolar proteinosis.
Bonella F; Sixt SU; Thomassen J; Schmidt M; Cai M; Mori T; Guzman J; Costabel U
Immunobiology; 2015 Mar; 220(3):382-8. PubMed ID: 25534398
[TBL] [Abstract][Full Text] [Related]
20. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis.
Honda Y; Takahashi H; Shijubo N; Kuroki Y; Akino T
Chest; 1993 Feb; 103(2):496-9. PubMed ID: 8432143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
